In this report, we describe the cases recovering from oral candidosis by treatment with oral ointment containing antifungal naphthoquinone derivatives. The patients bearing persistent colonization with Candida genera were treated with our domestic oral ointment, three times a day for two weeks or for one month. During the observation period, the oral candidosis was gradually vanished at 3 days after the treatment and disappeared completely at the end of the period. This ointment contains naphthoquinone derivatives, which are constituents of Shikon (root of Lithospermum erythrorhizon), having been investigated against several fungal pathogens. When the biological activity of these compounds was tested against fungi, a wide range of sensitivity was recorded. With the determination of these naphthoquinones by HPLC, this ointment contains about 10 to 100-folds of each effective concentration.
Materials and Methods Preparation of the Extracts and Tested Compounds
Lithospermum erythrorhizon marketed as Shikon was purchased from Tochimoto-Tenkai-do (Osaka). Deoxyshikonin, acetylshikonin, 3-hydroxyisovaleryl shikonin and shikonin were isolated from the chloroform extracts of L. erythrorhizon as described previously2. Preparation of oral ointment Lithospermum erythrorhizon (10g) was extracted with olive oil(100 ml) heated to 140C and filtered with sterilized gauze. This extraction oil (30ml) was added into white petrolatum (70g) giving oral ointment.
Determination of naphthoquirtone derivatives
Olive oil extract of Shikon was applied to Wakogel C-200 (Wako Chemical, Inc., Ltd., Kyoto, Japan) column to separate the naphthoquinones from fats and fatty oils. The CHC13 elute was concentrated in vacuo. The solution was put into a 5 ml measuring flask and then made to 5 ml with CHC13. The HPLC conditions were as follows: pump, W-515 (Waters, USA); UV-detector, W-2484 (k, =274 nm, Waters, USA); column, Lichrosphere RP-18 (e)(Cica-MERCK, USA); mobile phase, McOH-H2O-AcOH-CHCl3 (80:20:1:1); flow rate, 1.0 ml/min; column temperature, 30C.
Results
Concentration of Naphthoquinone derivatives HPLC profile of CHC13 extract is shown in Fig. 1 . The major four peaks were determined and each peak were identified as acetylshikonin, shikonin, 3-hydroxyisovaleryl shikonin and deoxyshikonin compared with the standarads isolated by the previous report. The concentrations were as follows: Acetylshikonin; 367. 5420.11 g/g, shikonin; 64. 470.52g/g, 3-hydroxyisovaleryl shikonin; 146.710.
43g/g and deoxyshikonin; 211.009. 34tg/g (Table 1 ). Clinical cases Case 1.
A 65-year-old woman with subarachnoidal hemorrhage swooning. After she had been hospitalized for 1 month, oral ulcer had diagnosed and Candida genera had been detected from an oral mucous membrane and/or ulcer tissue by cultivation test. Therapy with the oral ointment three times a day, about 15 g/day for two weeks was clinically successful. During the observation period, the oral candidosis was gradually vanished after 3 days treatment disappearing completely at the end of the period. The pictures of this progress are shown in Fig. 2 . Case 2.
A 74-year-old man with cerebral hemorrhage. After he had been hospitalized for 2 weeks, oral Fig. 1 ing from oral candidosis after two or four week's treatment. We certainly defined that this anti-inflammatory and/or anti-fungal activities of naphthoquinone derivatives had remedied a serious oral candidosis. We are not aware of any report that described alleviation of oral candidosis after any oral ointment therapy. In conclusion, we presented cases of refractory oral candidosis satisfactorily treatment with oral ointment containing naphthoquinone derivatives. This ointment may be effective not only in reducing the inflammation but also in preventing progression to oral-persistent colonization with Candida genera for the treatment of oral candidosis.
